Nordea Investment Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-117,500
Closed -$6.08M 1326
2019
Q1
$6.08M Sell
117,500
-35,248
-23% -$1.71M 0.01% 492
2018
Q4
$6.01M Buy
152,748
+2,885
+2% +$134K 0.01% 463
2018
Q3
$7.73M Buy
149,863
+75,718
+102% +$3.71M 0.02% 450
2018
Q2
$3.48M Buy
74,145
+2,941
+4% +$122K 0.01% 543
2018
Q1
$2.53M Buy
+71,204
New +$2.79M 0.01% 701

Other funds holding SYNH

Nordea Investment Management's SYNH Position: Q2 2019 in Review

Nordea Investment Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2019, closing a stake of 117,500 shares — an estimated $6.08M sold.

Nordea Investment Management first reported a position in SYNH in Q1 2018 and held it in 5 quarters. The position peaked at $7.73M in Q3 2018. 246 funds tracked by Wall St. Rank hold SYNH as of Q2 2019.

  • Nordea Investment Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2019 after selling out during the quarter.
  • Nordea Investment Management sold 117,500 Syneos Health, Inc. Class A Common Stock shares in Q2 2019, an estimated $6.08M.
  • Nordea Investment Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2018 and held it in 5 quarters.
  • Nordea Investment Management's Syneos Health, Inc. Class A Common Stock position peaked at $7.73M in Q3 2018.
  • 246 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2019.

Based on Nordea Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.